ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
27 déc. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan...
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
20 déc. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about...
ResMed Secures Significant Victory in Patent Fight Against New York University
11 déc. 2023 16h05 HE
|
ResMed Inc.
ResMed Secures Significant Victory in Patent Fight Against New York University
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
07 déc. 2023 15h34 HE
|
ResMed Inc.
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
ResMed Adopts New Operating Model to Accelerate Long-term Growth
09 nov. 2023 16h05 HE
|
ResMed Inc.
Justin Leong appointed Chief Product Officer, effective immediately.Katrin Pucknat appointed Chief Marketing Officer, effective immediately.Mike Fliss appointed Chief Revenue Officer, effective...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
26 oct. 2023 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 16%, operating profit up 5%, non-GAAP operating profit up 10%Expects to resume its share repurchase program during upcoming quarter Note: A webcast of ResMed’s conference...
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
05 oct. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday,...
ResMed Announces Participation in Upcoming Conferences
05 sept. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
03 août 2023 16h05 HE
|
ResMed Inc.
Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13%Quarterly dividend increases 9% to $0.48 per share Note: A webcast of ResMed’s conference call will be...
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
06 juil. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on...